Addex Pharmaceuticals (ADDXF.PK) announced the extension of its research collaboration with Merck & Co., Inc. (MRK), through an affiliate, for an additional year. The collaboration is focused on developing positive allosteric modulators of the metabotropic glutamate receptor 4 for the treatment of Parkinson's disease and other undisclosed indications.
Addex will receive research funding from Merck in addition to the original financial terms, which include milestones and royalties.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.